{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:57:50Z","timestamp":1795060670487,"version":"4.10.2"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec id=\"ab-eoi260013-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Retinopathy of prematurity (ROP) screening requires frequent examinations to avoid missed treatment-requiring disease, but this approach is burdensome for infants, families, and health systems. Whether precision risk models could reduce examination burden without compromising safety is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260013-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and externally validate an interpretable risk model integrating gestational age (GA), postmenstrual age (PMA), and vascular severity (artificial intelligence\u2013derived VSS or clinician-assigned P-score) to predict 2-week risk of treatment-requiring retinopathy of prematurity (TR-ROP) and estimate its impacts in screening frequency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260013-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This diagnostic study used data from the Imaging and Informatics in ROP (i-ROP) consortium (2011\u20132022) and the Stanford University Network for Diagnosis of ROP (SUNDROP; 2013\u20132021). The i-ROP dataset was split into training, validation, and test subsets, and SUNDROP served as an external validation cohort. A subset of i-ROP examinations with clinician assessment scores (P-scores) was analyzed for clinical adaptability. Data were analyzed from September 1, 2024, to September 1, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260013-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>GA, PMA, and vascular severity (VSS or P-score).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260013-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Discrimination (area under the receiver operating characteristic curve [AUROC], area under the precision-recall curve [AUPRC]), sensitivity, specificity for predicting TR-ROP within 2 weeks, and the proportion of examinations that could be deferred in a retrospective simulation while maintaining 100% sensitivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260013-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 559 infants in the i-ROP training dataset and 1544 in SUNDROP, infants who developed TR-ROP had a mean GA of 2.9 (95% CI, 2.3-3.5) weeks lower and birth weight of 391 (95% CI, 328-454) g than those who did not. Adding vascular severity improved discrimination vs GA alone (AUROC difference 0.13 [95% CI, 0.06-0.19] in i-ROP; 0.08 [95% CI, 0.03-0.14] in SUNDROP). A decision threshold achieved 100% sensitivity with moderate specificity (i-ROP 63%; SUNDROP 73%). Simulated risk-based scheduling reduced 28% (376 of 1384) of examinations in i-ROP and 39% (2356 of 6090 ) in SUNDROP without missing TR-ROP. Substituting P-scores for VSS preserved model performance (AUROC 0.87; 95% CI, 0.76-0.97; sensitivity 100%; 95% CI, 63%-100%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi260013-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, this validated clinically adaptable model provided individualized visit-level TR-ROP risk assessment with potential to improve screening efficiency by reducing unnecessary examinations without missing TR-ROP. The model will be made publicly available for further validation; however, prospective evaluation within a defined clinical workflow is required prior to routine implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.0510","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:30:27Z","timestamp":1775143827000},"page":"424","source":"Crossref","is-referenced-by-count":2,"title":["Precision Risk Model Using Quantitative Assessment of Vascular Severity in Telemedicine-Based Screening"],"prefix":"10.1001","volume":"144","author":[{"given":"John","family":"Placide","sequence":"first","affiliation":[{"name":"Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Coyner","sequence":"additional","affiliation":[{"name":"Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Ostmo","sequence":"additional","affiliation":[{"name":"Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius M.","family":"Moshfeghi","sequence":"additional","affiliation":[{"name":"Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Chiang","sequence":"additional","affiliation":[{"name":"National Eye Institute, Bethesda, Maryland"},{"name":"National Library of Medicine, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Kalpathy-Cramer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. V. Paul","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Colorado, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Young","sequence":"additional","affiliation":[{"name":"Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"Campbell","sequence":"additional","affiliation":[{"name":"Casey Eye Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"eoi260013r1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of prematurity: a global perspective and recent developments.","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"eoi260013r2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/peds.2004-1413","article-title":"The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study.","volume":"116","author":"Good","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"eoi260013r3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity.","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"issue":"3","key":"eoi260013r4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamaophthalmol.2014.5185","article-title":"Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study.","volume":"133","author":"Ying","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi260013r5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1177\/2474126419867634","article-title":"Telemedicine for retinopathy of prematurity in 2020.","volume":"3","author":"Bowe","year":"2019","journal-title":"J Vitreoretin Dis"},{"issue":"12","key":"eoi260013r6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jamaophthalmol.2018.4290","article-title":"Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.","volume":"136","author":"Quinn","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"eoi260013r7","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","article-title":"Development of modified screening criteria for retinopathy of prematurity: primary results from the Postnatal Growth and Retinopathy of Prematurity Study.","volume":"136","author":"Binenbaum","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"eoi260013r8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/archophthalmol.2009.69","article-title":"Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.","volume":"127","author":"L\u00f6fqvist","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"eoi260013r9","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening.","volume":"123","author":"Hellstr\u00f6m","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"eoi260013r10","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1542\/peds.2010-2240","article-title":"A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain.","volume":"127","author":"Binenbaum","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"eoi260013r11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/ijo.IJO_486_17","article-title":"WINROP algorithm for prediction of sight threatening retinopathy of prematurity: initial experience in Indian preterm infants.","volume":"66","author":"Sanghi","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"eoi260013r12","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/s41433-024-02953-1","article-title":"Validation of WINROP algorithm as screening tool of retinopathy of prematurity among Egyptian preterm neonates.","volume":"38","author":"Fares","year":"2024","journal-title":"Eye (Lond)"},{"issue":"4","key":"eoi260013r13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jcjo.2025.02.001","article-title":"G-ROP versus WINROP for retinopathy of prematurity screening: a Calgary perspective.","volume":"60","author":"Moorjani","year":"2025","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"eoi260013r14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamaophthalmol.2019.4502","article-title":"Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics.","volume":"138","author":"Pivodic","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"eoi260013r15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ophtha.2020.10.025","article-title":"Evaluation of a deep learning-derived quantitative retinopathy of prematurity severity scale.","volume":"128","author":"Campbell","year":"2021","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi260013r16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ophtha.2020.01.052","article-title":"Aggressive posterior retinopathy of prematurity: clinical and quantitative imaging features in a large North American cohort.","volume":"127","author":"Bellsmith","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi260013r17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamaophthalmol.2019.2433","article-title":"Monitoring disease progression with a quantitative severity scale for retinopathy of prematurity using deep learning.","volume":"137","author":"Taylor","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"eoi260013r18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ophtha.2024.05.019","article-title":"P score: a reference image-based clinical grading scale for vascular change in retinopathy of prematurity.","volume":"131","author":"Binenbaum","year":"2024","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi260013r19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-051772","article-title":"Single-examination risk prediction of severe retinopathy of prematurity.","volume":"148","author":"Coyner","year":"2021","journal-title":"Pediatrics"},{"issue":"8","key":"eoi260013r20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaophthalmol.2022.2135","article-title":"External validation of a retinopathy of prematurity screening model using artificial intelligence in 3 low- and middle-income populations.","volume":"140","author":"Coyner","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"eoi260013r21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited.","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"eoi260013r23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ajo.2025.07.017","article-title":"Long-term retinopathy of prematurity outcomes with mandated screening interval and grader continuity at a high-volume quaternary center.","volume":"279","author":"Zhao","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"eoi260013r24","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.18240\/ijo.2016.08.11","article-title":"Systemic changes and adverse effects induced by retinopathy of prematurity screening.","volume":"9","author":"Jiang","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"eoi260013r25","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313156","article-title":"Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity.","author":"Redd","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"eoi260013r26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.ophtha.2024.06.006","article-title":"Use of an artificial intelligence-generated vascular severity score improved plus disease diagnosis in retinopathy of prematurity.","volume":"131","author":"Coyner","year":"2024","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi260013r27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.51512","article-title":"Assessment of retinopathy of prematurity regression and reactivation using an artificial intelligence-based vascular severity score.","volume":"6","author":"Eilts","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"eoi260013r28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamaophthalmol.2023.1466","article-title":"Efficacy of smartphone-based telescreening for retinopathy of prematurity with and without artificial intelligence in India.","volume":"141","author":"Young","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"eoi260013r29","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100165","article-title":"Evaluation of an artificial intelligence system for retinopathy of prematurity screening in Nepal and","volume":"2","author":"Cole","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"eoi260013r30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ophtha.2023.03.026","article-title":"Epidemiologic evaluation of retinopathy of prematurity severity in a large telemedicine program in India using artificial intelligence.","volume":"130","author":"deCampos-Stairiker","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi260013r31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jamaophthalmol.2024.0045","article-title":"Multinational external validation of autonomous retinopathy of prematurity screening.","volume":"142","author":"Coyner","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"eoi260013r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2025.104696","article-title":"External validation of an artificial intelligence-based model for retinopathy of prematurity screening using Phoenix ICON retinal images.","volume":"29","author":"Derks","year":"2025","journal-title":"J AAPOS"},{"issue":"1","key":"eoi260013r33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0301-4738.126178","article-title":"The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting.","volume":"62","author":"Vinekar","year":"2014","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"eoi260013r34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3928\/01913913-20200804-01","article-title":"Development of screening criteria for retinopathy of prematurity in Ulaanbaatar, Mongolia, using a web-based data management system.","volume":"57","author":"Olson","year":"2020","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"eoi260013r22","unstructured":"2-Week TR-ROP risk calculator. Accessed February 25, 2026. https:\/\/i-rop.shinyapps.io\/weekly-risk-calculator\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2846894\/jamaophthalmology_placide_2026_oi_260013_1778698670.96769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:00:40Z","timestamp":1779375640000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2846894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.0510","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}